Experimental group . | Histopathological classification . | Incidence (%)* . |
---|---|---|
Group 1 | Carcinomas | 70 |
Papillomas | 10 | |
Cystoadenomas | 10 | |
Adenomas | 10 | |
Group 2 | Carcinomas | 33.3 |
Papillomas | 16.7 | |
Fibroadenomas | 33.3 | |
Fibroma | 16.7 | |
Group 5 | Carcinomas | 66.7 |
(Positive control) | Adenomas | 16.7 |
Cystoadenomas | 16.6 |
Experimental group . | Histopathological classification . | Incidence (%)* . |
---|---|---|
Group 1 | Carcinomas | 70 |
Papillomas | 10 | |
Cystoadenomas | 10 | |
Adenomas | 10 | |
Group 2 | Carcinomas | 33.3 |
Papillomas | 16.7 | |
Fibroadenomas | 33.3 | |
Fibroma | 16.7 | |
Group 5 | Carcinomas | 66.7 |
(Positive control) | Adenomas | 16.7 |
Cystoadenomas | 16.6 |
The number of neoplastic lesions in each histological category was divided by the total number of lesions observed in each experimental group